Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Tuberculosis

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 66 articles: HTML format Text format

Single Articles

December 2018
1. DESHPANDE D, Pasipanodya JG, Srivastava S, Martin KR, et al
   Minocycline Immunomodulates via Sonic Hedgehog Signaling and Apoptosis and Has Direct Potency Against Drug-Resistant Tuberculosis.
   J Infect Dis. 2018 Dec 28. pii: 5263980. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
2. FRANK DJ, Horne DJ, Dutta NK, Shaku MT, et al
   Remembering the Host in Tuberculosis Drug Development.
   J Infect Dis. 2018 Dec 21. pii: 5257354. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
3. KOEKEN VACM, Lachmandas E, Riza A, Matzaraki V, et al
   The role of glutamine metabolism for host defense against Mycobacterium tuberculosis infection.
   J Infect Dis. 2018 Dec 12. pii: 5239862. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   November 2018
4. SINHA P, Davis J, Saag L, Wanke C, et al
   Undernutrition and Tuberculosis: Public Health Implications.
   J Infect Dis. 2018 Nov 22. pii: 5197537. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
5. TOMASICCHIO M, Davids M, Pooran A, Theron G, et al
   The injectable contraceptive medroxyprogesterone acetate attenuates Mycobacterium tuberculosis-specific host immunity through the glucocorticoid receptor.
   J Infect Dis. 2018 Nov 19. pii: 5191220. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   October 2018
6. MAYITO J, Andia I, Belay M, Jolliffe DA, et al
   Anatomic and Cellular Niches for Mycobacterium tuberculosis in Latent Tuberculosis Infection.
   J Infect Dis. 2018 Oct 30. pii: 5146773. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
7. AMARAL EP, Machado de Salles E, Barbosa Bomfim CC, Salgado RM, et al
   Inhibiting Adenosine Receptor Signaling Promotes Accumulation of Effector CD4+ T Cells in the Lung Parenchyma During Severe Tuberculosis.
   J Infect Dis. 2018 Oct 11. pii: 5126506. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   September 2018
8. ARUMUGAM P, Shankaran D, Bothra A, Gandotra S, et al
   The MmpS6-MmpL6 operon is an oxidative stress response system providing selective advantage to Mycobacterium tuberculosis in stress.
   J Infect Dis. 2018 Sep 7. pii: 5092676. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   August 2018
9. SHIN SS, Modongo C, Baik Y, Allender C, et al
   Mixed infections are associated with poor treatment outcomes among newly diagnosed tuberculosis patients independent of pre-treatment heteroresistance.
   J Infect Dis. 2018 Aug 4. pii: 5066433. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   July 2018
10. GEBREMICAEL G, Kassa D, Quinten E, Alemayehu Y, et al
    Host gene expression kinetics during treatment of tuberculosis in HIV-coinfected individuals is independent of HAART therapy.
    J Infect Dis. 2018 Jul 2. pii: 5047436. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    June 2018
11. NELSON KN, Shah NS, Mathema B, Ismail N, et al
    Spatial Patterns of Extensively drug-resistant Tuberculosis (XDR-tuberculosis) transmission in KwaZulu-Natal, South Africa.
    J Infect Dis. 2018 Jun 28. pii: 5046349. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
12. ORDONEZ AA, Pokkali S, Sanchez-Bautista J, Klunk MH, et al
    Matrix Metalloproteinase Inhibition in a Murine Model of Cavitary Tuberculosis Paradoxically Worsens Pathology.
    J Infect Dis. 2018 Jun 16. pii: 5039594. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    May 2018
13. MAHLA RS
    KLRG1 Signaling is Contextual to Tuberculosis Immunity.
    J Infect Dis. 2018 May 28. pii: 5017236. doi: 10.1093.
    PubMed     Text format    
    
    
    
14. REICHLER MR, Khan A, Sterling TR, Zhao H, et al
    Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis.
    J Infect Dis. 2018 May 15. pii: 4996045. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
15. GUTHRIE JL, Delli Pizzi A, Roth D, Kong C, et al
    Genotyping and Whole Genome Sequencing to Identify Tuberculosis Transmission to Pediatric Patients in British Columbia, Canada, 2005-2014.
    J Infect Dis. 2018 May 11. pii: 4995040. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    April 2018
16. MILLER AC, Livchits V, Ahmad Khan F, Atwood S, et al
    Turning off the tap: Using the FAST approach to stop the spread of drug-resistant tuberculosis in Russian Federation.
    J Infect Dis. 2018 Apr 5. pii: 4961495. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
17. LACHMANDAS E, Rios-Miguel AB, Koeken VACM, van der Pasch E, et al
    Tissue metabolic changes drive cytokine responses to Mycobacterium tuberculosis.
    J Infect Dis. 2018 Apr 3. pii: 4959339. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    March 2018
18. URBANOWSKI ME, Ihms EA, Bigelow K, Kubler A, et al
    Repetitive Aerosol Exposure Promotes Cavitary Tuberculosis and Enables Screening for Targeted Inhibitors of Extensive Lung Destruction.
    J Infect Dis. 2018 Mar 15. pii: 4936447. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
19. MURRAY LW, Satti I, Meyerowitz J, Jones M, et al
    Human Immunodeficiency Virus Infection Impairs Th1 and Th17 Mycobacterium tuberculosis-Specific T-Cell Responses.
    J Infect Dis. 2018 Mar 13. pii: 4932783. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    February 2018
20. AGARWAL S, Tiwari P, Deep A, Kidwai S, et al
    System wide analysis unravels differential regulation and in vivo essentiality of VapBC TA systems from Mycobacterium tuberculosis.
    J Infect Dis. 2018 Feb 24. pii: 4909395. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
21. REECE ST, Vogelzang A, Tornack J, Bauer W, et al
    Mycobacterium tuberculosis-Infected Hematopoietic Stem and Progenitor Cells Unable to Express Inducible Nitric Oxide Synthase Propagate Tuberculosis in Mice.
    J Infect Dis. 2018 Feb 17. pii: 4869967. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
22. CHUNG YT, Pasquinelli V, Jurado JO, Wang X, et al
    Elevated cyclic AMP Inhibits Mycobacterium tuberculosis-stimulated T cell IFN-gamma Secretion through type I Protein Kinase A.
    J Infect Dis. 2018 Feb 8. pii: 4845549. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
23. KURODA MJ, Sugimoto C, Cai Y, Merino KM, et al
    High Turnover of Tissue Macrophages Contributes to Tuberculosis Reactivation in Simian Immunodeficiency Virus-Infected Rhesus Macaques.
    J Infect Dis. 2018 Feb 8. pii: 4843840. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
24. KHAN N, Divangahi M
    Mycobacterium tuberculosis and HIV Coinfection Brings Fire and Fury to Macrophages.
    J Infect Dis. 2018 Feb 8. pii: 4843841. doi: 10.1093.
    PubMed     Text format    
    
    
    January 2018
25. PAIDIPALLY P, Tripathi D, Van A, Radhakrishnan RK, et al
    IL-21 regulates NK cell responses during Mycobacterium tuberculosis infection.
    J Infect Dis. 2018 Jan 30. pii: 4829454. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
26. HU Z, Zhao HM, Li CL, Liu XH, et al
    The role of KLRG1 in human CD4+ T cell immunity against tuberculosis.
    J Infect Dis. 2018 Jan 24. pii: 4823593. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
27. THOMPSON EG, Shankar S, Gideon HP, Braun J, et al
    Blood RNA signatures prospectively discriminate controllers from progressors early after low-dose M. tuberculosis infection of cynomolgus macaques.
    J Infect Dis. 2018 Jan 8. pii: 4792952. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    December 2017
28. ZHENG R, Liu H, Zhou Y, Yan D, et al
    Notch4 Negatively Regulates the Inflammatory Response to Mycobacterium tuberculosis Infection by Inhibiting TAK1 Activation.
    J Infect Dis. 2017 Dec 8. pii: 4712145. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    November 2017
29. GARFIN C, Mantala M, Yadav R, Hanson CL, et al
    Using Patient Pathway Analysis to Design Patient-centered Referral Networks for Diagnosis and Treatment of Tuberculosis: The Case of the Philippines.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
30. HANSON C, Osberg M, Brown J, Durham G, et al
    Finding the Missing Patients With Tuberculosis: Lessons Learned From Patient-Pathway Analyses in 5 Countries.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
31. HANSON CL, Osberg M, Brown J, Durham G, et al
    Conducting Patient-Pathway Analysis to Inform Programming of Tuberculosis Services: Methods.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
32. MASINI E, Hanson C, Ogoro J, Brown J, et al
    Using Patient-Pathway Analysis to Inform a Differentiated Program Response to Tuberculosis: The Case of Kenya.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
33. FATIMA R, Haq MU, Yaqoob A, Mahmood N, et al
    Delivering Patient-Centered Care in a Fragile State: Using Patient-Pathway Analysis to Understand Tuberculosis-Related Care Seeking in Pakistan.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
34. SURYA A, Setyaningsih B, Suryani Nasution H, Gita Parwati C, et al
    Quality Tuberculosis Care in Indonesia: Using Patient Pathway Analysis to Optimize Public-Private Collaboration.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
35. FEKADU L, Hanson C, Osberg M, Makayova J, et al
    Increasing Access to Tuberculosis Services in Ethiopia: Findings From a Patient-Pathway Analysis.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
36. SISMANIDIS C, Shete PB, Lienhardt C, Floyd K, et al
    Harnessing the Power of Data to Guide Local Action and End Tuberculosis.
    J Infect Dis. 2017;216.
    PubMed     Text format    
    
    
    
37. REID MJA, Goosby E
    Patient-Centered Tuberculosis Programs Are Necessary to End the Epidemic.
    J Infect Dis. 2017;216.
    PubMed     Text format    
    
    
    
38. CHIN DP, Hanson CL
    Finding the Missing Tuberculosis Patients.
    J Infect Dis. 2017;216.
    PubMed     Text format    
    
    
    
39. NAIDOO P, Theron G, Rangaka MX, Chihota VN, et al
    The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
40. CHURCHYARD G, Kim P, Shah NS, Rustomjee R, et al
    What We Know About Tuberculosis Transmission: An Overview.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
41. TURNER RD, Chiu C, Churchyard GJ, Esmail H, et al
    Tuberculosis Infectiousness and Host Susceptibility.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
42. MATHEMA B, Andrews JR, Cohen T, Borgdorff MW, et al
    Drivers of Tuberculosis Transmission.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
43. AULD SC, Kasmar AG, Dowdy DW, Mathema B, et al
    Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
44. DOWDY DW, Grant AD, Dheda K, Nardell E, et al
    Designing and Evaluating Interventions to Halt the Transmission of Tuberculosis.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
45. SHAH NS, Kim P, Kana BD, Rustomjee R, et al
    Getting to Zero New Tuberculosis Infections: Insights From the National Institutes of Health/US Centers for Disease Control and Prevention/Bill & Melinda Gates Foundation Workshop on Research Needs for Halting Tuberculosis Transmission.
    J Infect Dis. 2017;216.
    PubMed     Text format    
    
    
    
46. SALVATORE PP, Proano A, Kendall EA, Gilman RH, et al
    Linking individual natural history to population outcomes in tuberculosis.
    J Infect Dis. 2017 Nov 2. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    October 2017
47. AGORO R, Benmerzoug S, Rose S, Bouyer M, et al
    An Iron-Rich Diet Decreases the Mycobacterial Burden and Correlates With Hepcidin Upregulation, Lower Levels of Proinflammatory Mediators, and Increased T-Cell Recruitment in a Model of Mycobacterium bovis Bacille Calmette-Guerin Infection.
    J Infect Dis. 2017;216:907-918.
    PubMed     Text format     Abstract available
    
    
    
48. BUNJUN R, Riou C, Soares AP, Thawer N, et al
    Effect of HIV on the frequency and number of Mycobacterium tuberculosis-specific CD4+ T cells in blood and the airways in latent tuberculosis infection.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    September 2017
49. ROCKWOOD N, Sirgel F, Streicher E, Warren R, et al
    Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
    J Infect Dis. 2017;216:632-640.
    PubMed     Text format     Abstract available
    
    
    August 2017
50. SINGH V, Prakhar P, Rajmani RS, Mahadik K, et al
    Histone Methyltransferase SET8 Epigenetically Reprograms Host Immune Responses to Assist Mycobacterial Survival.
    J Infect Dis. 2017;216:477-488.
    PubMed     Text format     Abstract available
    
    
    June 2017
51. FOLKVARDSEN DB, Norman A, Andersen AB, Rasmussen EM, et al
    Genomic epidemiology of a major Mycobacterium tuberculosis outbreak: Retrospective cohort study in a low incidence setting using sparse time-series sampling.
    J Infect Dis. 2017 Jun 28. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
52. GUPTA S, Cheung L, Pokkali S, Winglee K, et al
    Suppressor Cell-Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis.
    J Infect Dis. 2017;215:1883-1887.
    PubMed     Text format     Abstract available
    
    
    May 2017
53. YAO Y, Lai R, Afkhami S, Haddadi S, et al
    A novel virus-vectored respiratory mucosal vaccine enhances anti-tuberculosis immunity in a humanized model system.
    J Infect Dis. 2017 May 20. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
54. ANTHONY RM
    Sputum microscopy and tuberculosis infectiousness.
    J Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format    
    
    
    
55. DATTA S, Sherman JM, Tovar MA, Bravard MA, et al
    Sputum microscopy with fluorescein diacetate predicts tuberculosis infectiousness.
    J Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    April 2017
56. THUONG NTT, Heemskerk D, Tram TTB, Thao LTP, et al
    Leukotriene A4 Hydrolase Genotype and HIV Infection Influence Intracerebral Inflammation and Survival From Tuberculous Meningitis.
    J Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    March 2017
57. OEHLERS SH, Cronan MR, Beerman RW, Johnson MG, et al
    Infection-Induced Vascular Permeability Aids Mycobacterial Growth.
    J Infect Dis. 2017;215:813-817.
    PubMed     Text format     Abstract available
    
    
    February 2017
58. HALLIDAY A, Whitworth H, Hermagild Kottoor S, Niazi U, et al
    Stratification of latent tuberculosis infection by cellular immune profiling.
    J Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
59. SHEN H, Gu J, Xiao H, Liang S, et al
    Selective Destruction of Interleukin 23-Induced Expansion of a Major Antigen-Specific gammadelta T-Cell Subset in Patients With Tuberculosis.
    J Infect Dis. 2017;215:420-430.
    PubMed     Text format     Abstract available
    
    
    January 2017
60. CLARK S, Lanni F, Marinova D, Rayner E, et al
    Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
    J Infect Dis. 2017 Jan 25. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
61. JANSSEN S, Schutz C, Ward AM, Huson MA, et al
    Hemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort Study.
    J Infect Dis. 2017;215:247-258.
    PubMed     Text format     Abstract available
    
    
    December 2016
62. MARAIS S, Lai RP, Wilkinson KA, Meintjes G, et al
    Inflammasome activation underlies central nervous system deterioration in HIV-associated tuberculosis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    October 2016
63. JEYANATHAN M, Damjanovic D, Yao Y, Bramson J, et al
    Induction of an immune protective T cell repertoire with diverse genetic coverage by a novel viral-vectored tuberculosis vaccine in man.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    September 2016
64. MARTINEZ N, Ketheesan N, West K, Vallerskog T, et al
    Impaired Recognition of Mycobacterium tuberculosis by Alveolar Macrophages from Diabetic Mice.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    August 2016
65. SINGH DK, Dwivedi VP, Ranganathan A, Bishai WR, et al
    Blockade of the Kv1.3 K+ channel enhances BCG vaccine efficacy by expanding central memory T lymphocytes.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    July 2016
66. CANADAY DH, Toossi Z
    Granulomatous responses in HIV/TB co-infection.
    J Infect Dis. 2016.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: